who makes semaglutide which company FDA issues warning about some compounded versions of for diabetes, weight loss Hims & Hers makes deal – Indian companies rush to make

Over the last few years, several regulatory authorities, such as the FDA and EMA, reported the incidence of mood alterations, depressive symptoms, and even suicidal thoughts with the use of GLP-1 receptor agonists during the pharmacovigilance surveillance process, which raises the issue of their psychiatric safety [13,14,15]

Zepbound is approved for chronic weight management and for moderate to severe obstructive sleep apnea

By reducing hunger signals to the brain, slowing digestion so food stays in the stomach longer, and improving insulin sensitivity, these drugs make it easier to eat less, feel full sooner, and maintain more stable blood sugar levels

Dietary fat and risk of inflammatory bowel disease: a meta-analysis